| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000259820.1 |
Tanespimycin |
Brain lower grade glioma |
0.021594656 |
Resistant |
| ENSG00000259820.1 |
Tanespimycin |
Lung squamous cell carcinoma |
0.001734907 |
Resistant |
| ENSG00000259820.1 |
Tanespimycin |
Colon adenocarcinoma |
0.01919973 |
Sensitive |
